Is MOH a good stock to buy right now?

Based on our 6-factor quantitative model, MOLINA HEALTHCARE, INC. (MOH) receives a "Reduce" rating with a composite score of 34.0/100. It is ranked #3,351 out of 4,446 stocks. Key factor scores: Quality 10/100, Value 74/100, Momentum 19/100. The timing signal is "Neutral". This is quantitative analysis only — not investment advice.

What is the stock rating for MOH?

MOLINA HEALTHCARE, INC. (MOH) has a "Reduce" rating and 2-star score. The composite score of 34.0 ranks it #3,351 among 4,446 U.S. stocks. Ratings are updated weekly using academically-proven factor models.

What sector is MOH in?

MOLINA HEALTHCARE, INC. operates in the Financials sector (Insurance industry) with a market cap of $7.08 billion. It is classified as a mid-cap stock.

Does MOH pay a dividend?

MOH does not currently pay a regular dividend. The company may be reinvesting profits for growth.

What is MOH's P/E ratio?

MOH has a trailing P/E ratio of 7.70x. The Financials sector average is 14.9x. This below-average P/E may indicate the stock is undervalued.

How profitable is MOH?

MOH's quality factor score is 10/100. Gross margin: 14.5%. ROE: 23.5% vs sector average 8.5%. Margins are moderate to low, reflecting competitive market dynamics.

How is MOH valued compared to peers?

MOH's value factor score is 74/100 (higher = cheaper). Key multiples: P/E 7.7x, EV/EBITDA 4.6x. The stock appears attractively valued versus peers.

What is MOH's debt level?

MOH's debt-to-equity ratio is 283%. Sector average: 121%. Elevated leverage increases credit risk.

MOH has a beta of 0.04, meaning it is less volatile than the market. Stability score: 57/100.

Does MOH have high short interest?

MOH's short interest factor score is 69/100 (higher = less short selling). Moderate short interest.

MOH Stock Analysis: Top Mid-Cap Reduce (Score 34.0/100) | Blank Capital Research

Data Series	1D	5D	1M	YTD	1Y	3Y	5Y	10Y
MOH	+0.57%	+4.66%	+3.23%	-15.94%	-57.43%	-	-	-
Industry Proxy XLF	-1.09%	+2.50%	+1.42%	-7.30%	+10.59%	-	-	-
U.S. Market SPY	-0.07%	+3.60%	+0.34%	-0.36%	+29.52%	-	-	-
Alpha vs Market	+0.64%	+1.06%	+2.89%	-15.58%	-86.95%	-	-	-
Alpha vs Sector	+1.66%	+2.16%	+1.81%	-8.64%	-68.02%	-	-	-

Metric	MOH	Benchmark
P/E Ratio	7.7x	-48%
EV/EBITDA	4.6x	+40%
Price / Book	1.8x

Stock Entity	Score▼	Quality	Value	Momentum	P/E Ratio	ROE	Gross Margin	Net Margin	Rev Growth	D/E Ratio	Market Cap	Compare
WTM WHITE MOUNTAINS INSURANCE GROUP LTD	63	80	79	54	8.9x	10.1%	96.3%	20.1%	1.6%	14.0x	$5.4B	VS
OPY OPPENHEIMER HOLDINGS INC	63	68	79	63	10.4x	9.9%	0.0%	6.5%	37.5%	273.0x	$959M	VS
ACT Enact Holdings, Inc.	62	81	76	52	8.7x	12.7%	88.5%	55.0%	4.2%	14.0x	$5.7B	VS
IGIC International General Insurance Holdings Ltd.	61	74	93	50	8.6x	82.6%	59.9%	25.1%	-	0.0x	$1.1B	VS
PKBK PARKE BANCORP, INC.	60	60	77	65	9.8x	10.5%	-	24.8%	20.9%	593.0x	$335M	VS
SSSS SURO CAPITAL CORP.	60	89	33	65	4.7x	30.9%	0.0%	-752.0%	-48.3%	34.0x	$290M	VS
CB Chubb Ltd	59	67	71	52	12.8x	12.5%	0.0%	16.6%	15.6%	20.0x	$128.0B	VS
RRBI RED RIVER BANCSHARES INC	59	59	69	68	15.0x	11.0%	0.0%	27.5%	13.3%	818.0x	$607M	VS
UFCS UNITED FIRE GROUP INC	59	64	78	58	9.8x	10.6%	100.0%	7.3%	17.5%	308.0x	$936M	VS
SPFI SOUTH PLAINS FINANCIAL, INC.	58	59	73	55	12.8x	11.0%	0.0%	21.7%	9.0%	807.0x	$690M	VS
MOH MOLINA HEALTHCARE, INC.	34	10	74	19	7.7x	23.5%	14.5%	2.2%	16.2%	283.0x	$7.1B

Key Ratio	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Gross Margin %	0.1%	0.1%	0.2%	0.2%	0.2%	0.1%	0.2%	0.2%	0.2%	0.1%	1.0%
Operating Margin %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.1%	0.1%	-0.0%	0.0%
EBITDA Margin %	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.1%	0.1%	0.1%	-0.0%	0.0%
Net Margin %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	-0.0%	0.0%
FCF Margin %	-3.1%	-	-	-	-	-	9.3%	2.2%	-1.8%	3.6%	2.8%
ROE %	0.2%	0.1%	0.3%	0.3%	0.3%	0.3%	0.3%	0.4%	0.4%	-0.4%	0.0%
ROA %	0.1%	0.0%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	-0.1%	0.0%
ROIC %	31.7%	15.2%	30.0%	29.5%	31.3%	30.6%	1,234.2%	110.7%	320.2%	-137.0%	50.9%

Key Ratio

TTM

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

Gross Margin %

0.1%

0.2%

0.1%

0.2%

0.1%

1.0%

Operating Margin %

0.0%

0.1%

-0.0%

0.0%

EBITDA Margin %

0.0%

0.1%

0.0%

0.1%

-0.0%

0.0%

Net Margin %

0.0%

-0.0%

0.0%

FCF Margin %

-3.1%

9.3%

2.2%

-1.8%

3.6%

2.8%

ROE %

0.2%

0.1%

0.3%

0.4%

-0.4%

0.0%

ROA %

0.1%

0.0%

0.1%

-0.1%

0.0%

ROIC %

31.7%

15.2%

30.0%

29.5%

31.3%

30.6%

1,234.2%

110.7%

320.2%

-137.0%

50.9%

Line Item	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
	$44.4B	$45.4B	$40.6B	$34.1B	$32.0B	$27.8B	$19.4B	$16.8B	$18.9B	$19.9B	$17.8B	$14.2B
	—	$39.5B	$34.4B	$28.7B	$27.2B	$23.7B	—	—	—	—	—	—
	$6.4B	$5.9B	$6.2B	$5.4B	$4.8B	$4.1B	$3.6B	$2.9B	$3.4B	$2.3B	$17.3B	$14.0B
Gross Margin	14.5%	13.1%	15.3%	15.9%	15.0%	14.6%	18.6%	17.4%	17.9%	11.7%	97.3%	98.6%
	—	$195M	$186M	$171M	$176M	$131M	$88M	$89M	$127M	$210M	$213M	$156M
Total Operating Expenses	—	$5.2B	$4.5B	$3.8B	$3.6B	$3.0B	—	—	—	—	—	—
	$1.4B	$781M	$1.7B	$1.6B	$1.2B	$1.0B	$1.1B	$1.0B	$1.1B	-$555M	$306M	$387M
EBIT	$1.4B	$781M	$1.7B	$1.6B	$1.2B	$1.0B	$1.1B	$1.0B	$1.1B	-$555M	$306M	$387M
EBITDA	$1.6B	$976M	$1.9B	$1.7B	$1.3B	$1.2B	$1.2B	$1.1B	$1.2B	-$284M	$519M	$544M
Operating Margin	3.2%	1.7%	4.2%	4.6%	3.7%	3.7%	5.5%	6.2%	6.0%	-2.8%	1.7%	2.7%
EBITDA Margin	3.6%	2.1%	4.7%	5.1%	4.2%	4.1%	5.9%	6.8%	6.6%	-1.4%	2.9%	3.8%
	—	—	—	$109M	$110M	$120M	$102M	$87M	$115M	$118M	$101M	$66M
	—	$589M	$1.6B	$1.5B	$1.1B	$875M	—	—	—	—	—	—
Income Tax Expense	—	$117M	$410M	$373M	$271M	$216M	$288M	$235M	$292M	-$100M	$153M	$179M
	$958M	$472M	$1.2B	$1.1B	$792M	$659M	$673M	$737M	$707M	-$512M	$52M	$143M
Net Margin	2.2%	1.0%	2.9%	3.2%	2.5%	2.4%	3.5%	4.4%	3.7%	-2.6%	0.3%	1.0%
	$8.93	$8.93	$20.52	$18.91	$13.72	$11.40	$11.40	$11.85	$11.57	$-9.07	$0.93	$2.75
Diluted EPS	$8.93	$8.92	$20.42	$18.77	$13.55	$11.25	$11.40	$11.85	$11.57	$-9.07	$0.93	$2.75
Weighted Avg Basic	—	53M	57M	58M	58M	58M	—	—	—	—	—	—
Weighted Avg Diluted	—	53M	58M	58M	59M	59M	—	—	—	—	—	—

Line Item

TTM

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

$44.4B

$45.4B

$40.6B

$34.1B

$32.0B

$27.8B

$19.4B

$16.8B

$18.9B

$19.9B

$17.8B

$14.2B

—

$39.5B

$34.4B

$28.7B

$27.2B

$23.7B

—

$6.4B

$5.9B

$6.2B

$5.4B

$4.8B

$4.1B

$3.6B

$2.9B

$3.4B

$2.3B

$17.3B

$14.0B

Gross Margin

14.5%

13.1%

15.3%

15.9%

15.0%

14.6%

18.6%

17.4%

17.9%

11.7%

97.3%

98.6%

—

$195M

$186M

$171M

$176M

$131M

$88M

$89M

$127M

$210M

$213M

$156M

Total Operating Expenses

—

$5.2B

$4.5B

$3.8B

$3.6B

$3.0B

—

$1.4B

$781M

$1.7B

$1.6B

$1.2B

$1.0B

$1.1B

$1.0B

$1.1B

-$555M

$306M

$387M

EBIT

$1.4B

$781M

$1.7B

$1.6B

$1.2B

$1.0B

$1.1B

$1.0B

$1.1B

-$555M

$306M

$387M

EBITDA

$1.6B

$976M

$1.9B

$1.7B

$1.3B

$1.2B

$1.1B

$1.2B

-$284M

$519M

$544M

Operating Margin

3.2%

1.7%

4.2%

4.6%

3.7%

5.5%

6.2%

6.0%

-2.8%

1.7%

2.7%

EBITDA Margin

3.6%

2.1%

4.7%

5.1%

4.2%

4.1%

5.9%

6.8%

6.6%

-1.4%

2.9%

3.8%

—

$109M

$110M

$120M

$102M

$87M

$115M

$118M

$101M

$66M

—

$589M

$1.6B

$1.5B

$1.1B

$875M

—

Income Tax Expense

—

$117M

$410M

$373M

$271M

$216M

$288M

$235M

$292M

-$100M

$153M

$179M

$958M

$472M

$1.2B

$1.1B

$792M

$659M

$673M

$737M

$707M

-$512M

$52M

$143M

Net Margin

2.2%

1.0%

2.9%

3.2%

2.5%

2.4%

3.5%

4.4%

3.7%

-2.6%

0.3%

1.0%

$8.93

$20.52

$18.91

$13.72

$11.40

$11.85

$11.57

$-9.07

$0.93

$2.75

Diluted EPS

$8.93

$8.92

$20.42

$18.77

$13.55

$11.25

$11.40

$11.85

$11.57

$-9.07

$0.93

$2.75

Weighted Avg Basic

—

53M

57M

58M

—

Weighted Avg Diluted

—

53M

58M

59M

—

MOLINA HEALTHCARE, INC. (MOH) Stock Analysis — April 2026 Rating, Price, and Forecast

Last updated: April 2026

Company Overview — What Does MOLINA HEALTHCARE, INC. Do?

Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is headquartered in Long Beach, California. MOLINA HEALTHCARE, INC. (MOH) is classified as a mid-cap stock in the Financials sector, specifically within the Insurance industry. The company is led by CEO Joseph M. Zubretsky and employs approximately 15,000 people, headquartered in Long Beach, California. With a market capitalization of $7.1B, MOH is one of the notable companies in the Financials sector.

MOLINA HEALTHCARE, INC. (MOH) Stock Rating — Reduce (April 2026)

As of April 2026, MOLINA HEALTHCARE, INC. receives a Reduce rating with a composite score of 34.0/100 and 2 out of 5 stars from the Blank Capital Research quantitative model.MOH ranks #3,351 out of 4,446 stocks in our coverage universe. Within the Financials sector, MOLINA HEALTHCARE, INC. ranks #764 of 891 stocks, placing it in the lower half of its Financials peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

MOH Stock Price and 52-Week Range

MOLINA HEALTHCARE, INC. (MOH) currently trades at $145.88. The stock gained $0.83 (0.6%) in the most recent trading session. The 52-week high for MOH is $359.97, which means the stock is currently trading -59.5% from its annual peak. The 52-week low is $121.06, putting the stock 20.5% above its annual trough. Recent trading volume was 759K shares, suggesting relatively thin trading activity.

Is MOH Overvalued or Undervalued? — Valuation Analysis

MOLINA HEALTHCARE, INC. (MOH) carries a value factor score of 74/100 in the Blank Capital model, suggesting the stock trades at a meaningful discount to its fundamental earning power. The trailing price-to-earnings ratio is 7.70x, compared to the Financials sector average of 14.88x — a discount of 48%. The price-to-book ratio stands at 1.81x, versus the sector average of 1.22x. The price-to-sales ratio is 0.17x, compared to 0.90x for the average Financials stock. On an enterprise value basis, MOH trades at 4.58x EV/EBITDA, versus 3.26x for the sector.

Based on these multiples, MOLINA HEALTHCARE, INC. appears attractively valued relative to both its sector peers and the broader market. Value-oriented investors may find the current entry point compelling, particularly if the company's fundamental quality metrics also score well.

MOLINA HEALTHCARE, INC. Profitability — ROE, Margins, and Quality Score

MOLINA HEALTHCARE, INC. (MOH) earns a quality factor score of 10/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is 23.5%, compared to the Financials sector average of 8.5%, which demonstrates strong shareholder value creation. Return on assets (ROA) comes in at 6.2% versus the sector average of 1.2%.

On a margin basis, MOLINA HEALTHCARE, INC. reports gross margins of 14.5%. The operating margin is 3.2% (sector: 21.8%). Net profit margin stands at 2.2%, versus 17.7% for the average Financials stock. Revenue growth is running at 16.2% on a trailing basis, compared to 9.4% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.

MOH Debt, Balance Sheet, and Financial Health

MOLINA HEALTHCARE, INC. has a debt-to-equity ratio of 283.0%, compared to the Financials sector average of 121.0%. This elevated leverage warrants close monitoring, as it increases the company's sensitivity to rising interest rates and economic downturns. The current ratio is 1.69x, suggesting adequate working capital coverage. Total debt on the balance sheet is $3.66B. Cash and equivalents stand at $4.22B.

MOH has a beta of 0.04, meaning it is less volatile than the S&P 500, making it a relatively defensive holding. The stability factor score for MOLINA HEALTHCARE, INC. is 57/100, reflecting average volatility within the normal range for its sector.

MOLINA HEALTHCARE, INC. Revenue and Earnings History — Quarterly Trend

In TTM 2026, MOLINA HEALTHCARE, INC. reported revenue of $44.39B and earnings per share (EPS) of $8.93. Net income for the quarter was $958M. Gross margin was 14.5%. Operating income came in at $1.41B.

In FY 2025, MOLINA HEALTHCARE, INC. reported revenue of $45.43B and earnings per share (EPS) of $8.93. Net income for the quarter was $472M. Gross margin was 13.1%. Revenue grew 11.7% year-over-year compared to FY 2024. Operating income came in at $781M.

In Q3 2025, MOLINA HEALTHCARE, INC. reported revenue of $11.48B and earnings per share (EPS) of $1.51. Net income for the quarter was $79M. Gross margin was 12.5%. Revenue grew 11.0% year-over-year compared to Q3 2024. Operating income came in at $137M.

In Q2 2025, MOLINA HEALTHCARE, INC. reported revenue of $11.43B and earnings per share (EPS) of $4.75. Net income for the quarter was $255M. Gross margin was 14.0%. Revenue grew 15.7% year-over-year compared to Q2 2024. Operating income came in at $373M.

Over the past 8 quarters, MOLINA HEALTHCARE, INC. has demonstrated a growth trajectory, with revenue expanding from $9.88B to $44.39B. Investors analyzing MOH stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

MOH Dividend Yield and Income Analysis

MOLINA HEALTHCARE, INC. (MOH) does not currently pay a dividend. This is common among smaller companies in the Insurance industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Financials dividend stocks may want to explore other Financials stocks or use the stock screener to filter by dividend yield.

MOH Momentum and Technical Analysis Profile

MOLINA HEALTHCARE, INC. (MOH) has a momentum factor score of 19/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 27/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 69/100 reflects moderate short selling activity.

MOH vs Competitors — Financials Sector Ranking and Peer Comparison

Within the Financials sector, MOLINA HEALTHCARE, INC. (MOH) ranks #764 out of 891 stocks based on the Blank Capital composite score. This places MOH in the lower half of all Financials stocks in our coverage universe. Key competitors and sector peers include WHITE MOUNTAINS INSURANCE GROUP LTD (WTM) with a score of 62.9/100, OPPENHEIMER HOLDINGS INC (OPY) with a score of 62.6/100, Enact Holdings, Inc. (ACT) with a score of 61.6/100, International General Insurance Holdings Ltd. (IGIC) with a score of 61.3/100, and PARKE BANCORP, INC. (PKBK) with a score of 60.4/100.

Comparing MOH against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full MOH vs S&P 500 (SPY) comparison to assess how MOLINA HEALTHCARE, INC. stacks up against the broader market across all factor dimensions.

MOH Next Earnings Date

No upcoming earnings date has been announced for MOLINA HEALTHCARE, INC. (MOH) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy MOH? — Investment Thesis Summary

The quantitative profile for MOLINA HEALTHCARE, INC. suggests caution. The quality score of 10/100 flags below-average profitability. The value score of 74/100 suggests attractive pricing relative to fundamentals. Momentum is weak at 19/100, a headwind for near-term performance.

In summary, MOLINA HEALTHCARE, INC. (MOH) earns a Reduce rating with a composite score of 34.0/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on MOH stock.

Related Resources for MOH Investors

Explore more research and tools: MOH vs S&P 500 comparison, top Financials stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare MOH head-to-head with peers: MOH vs WTM, MOH vs OPY, MOH vs ACT.

Business quality

Valuation edge

Market alpha

Unlock Investment Thesis

Unlock Performance & Technicals

Unlock Valuation Tools

Institutional peer matrix

Dispersion: efficiency vs. valuation

Lateral intelligence network

Unlock Financial Statements

Unlock Ownership & Management

Intelligence Feed

UnitedHealth, Humana, CVS Jump As CMS Boosts Medicare Payments

Shares of health insurance companies are trading higher after the Centers for Medicare & Medicaid Services announced a 2.48% rate hike for 2027 Medicare Advantage and Part D programs.

Medicare Finalizes 2.48% Rate Hike For Private Insurers In 2027

Did Higher 2027 Medicare Advantage Rates Just Shift Molina Healthcare's (MOH) Margin and Valuation Narrative?

CMS Issues Guidance On New Limits For Federal Medicaid & CHIP Funding Restrictions For Noncitizens; States Will Need To Implement Statutory Changes By October 1 2026

Unlock Earnings Transcripts

Institutional Intelligence FAQ

Related Research & Tools

Related Financials Stocks

MOLINA HEALTHCARE, INC. (MOH) Stock Analysis — April 2026 Rating, Price, and Forecast

Company Overview — What Does MOLINA HEALTHCARE, INC. Do?

MOLINA HEALTHCARE, INC. (MOH) Stock Rating — Reduce (April 2026)

MOH Stock Price and 52-Week Range

Is MOH Overvalued or Undervalued? — Valuation Analysis

MOLINA HEALTHCARE, INC. Profitability — ROE, Margins, and Quality Score

MOH Debt, Balance Sheet, and Financial Health

MOLINA HEALTHCARE, INC. Revenue and Earnings History — Quarterly Trend

MOH Dividend Yield and Income Analysis

MOH Momentum and Technical Analysis Profile

MOH vs Competitors — Financials Sector Ranking and Peer Comparison

MOH Next Earnings Date

Should You Buy MOH? — Investment Thesis Summary

Related Resources for MOH Investors

Comments

Institutional Benchmarks

Get alerted on rating changes

Intelligence Feed

UnitedHealth, Humana, CVS Jump As CMS Boosts Medicare Payments

Shares of health insurance companies are trading higher after the Centers for Medicare & Medicaid Services announced a 2.48% rate hike for 2027 Medicare Advantage and Part D programs.

Medicare Finalizes 2.48% Rate Hike For Private Insurers In 2027

Did Higher 2027 Medicare Advantage Rates Just Shift Molina Healthcare's (MOH) Margin and Valuation Narrative?

CMS Issues Guidance On New Limits For Federal Medicaid & CHIP Funding Restrictions For Noncitizens; States Will Need To Implement Statutory Changes By October 1 2026